Publications

International Peer Reviewed Publications (impact factor in brackets)

Bijlsma MJ, Tarkiainen L, Myrskylä M, Martikainen P. Unemployment and subsequent depression: a mediation analysis using the parametric G-formula. Social Science & Medicine 2017;194: 142-150. (IF: 2.797). Link (Open Access).

Bijlsma MJ, Daniel RM, Janssen F, De Stavola BL. An assessment and extension of the mechanism-based approach to the identification of age-period-cohort models. Demography 2017; 54: 721-743. (IF: 2.800, the top journal in Demography). Link (Open Access).

Darvishian M, Dijkstra F, Van Doorn E, Bijlsma MJ, Donker GA, De Lange MA, Cadenau LM, Hak E, Meijer A. Influenza vaccine effectiveness in the Netherlands from 2003/2004 through 2013/2014: the importance of circulating influenza virus types and subtypes. PLoS One. 2017 9;12(1).  (IF: 3.057)

Trias-Llimós S, Bijlsma MJ, Janssen F. The role of birth cohorts in long-term trends in liver cirrhosis mortality across eight European countries. Addiction 2017;112(2):250-258. (IF: 4.97, the top journal in category ‘Substance abuse’).

Nguyen TP, Wright EP, Nguyen TT, Schuiling-Veninga CC, Bijlsma MJ, Nguyen TB, Postma MJ. Cost-effectiveness analysis of screening for and managing identified hypertension for cardiovascular disease prevention in Vietnam. PLoS One. 2016; 11(5):e0155699. (IF: 3.057)

Bijlsma MJ, Vansteelandt S, Janssen F, Hak E. The effect of adherence to statin therapy on cardiovascular mortality: quantification of unmeasured bias using falsification end-points. BMC Public Health. 2016 11;16:303. (IF: 2.264)

Berm EJJ, Odigie B, Bijlsma MJ, Wilffert B, Touw DJ, Maring JG. A clinical validation study for application of dried blood spots in therapeutic drug monitoring of antidepressants. Bioanalysis 2016; 8(5):413-24. (IF: 3.003)

Bijlsma MJ, Janssen F, Hak E. Estimating time-varying drug adherence using electronic records: extending the Proportion of Days Covered (PDC) method. Pharmacoepidemiology & Drug Safety 2016; 25(3):325-32. (IF: 2.94)

Bijlsma MJ, Janssen F, Bos HJ, Kamphuisen PW, Vansteelandt S, Hak E. Brief Report: Association Between Statin Use and Cardiovascular Mortality at the Population Level: An Ecologic Study. Epidemiology 2015;26(6):802-5. (IF: 6.18)

Bijlsma MJ, Janssen F, Lub R, Bos HJ, De Vries FM, Vansteelandt S, Hak E. Birth cohort appeared to confound effect estimates of guideline changes on statin utilization. Journal of Clinical Epidemiology 2015; 68(3):334-40 (IF: 3.42)

Kröpelin TF, de Zeeuw D, Andress DL, Bijlsma MJ, Persson F, Parving HH, Lambers Heerspink HJ. Number and Frequency of Albuminuria Measurements in Clinical Trials in Diabetic Nephropathy. Clinical Journal of the American Society of Nephrology 2015; 10(3):410-6. (IF: 5.25)

Darvishian M, Bijlsma MJ, Hak E, Van den Heuvel ER. Seasonal influenza vaccine effectiveness among the community-dwelling elderly: a meta-analysis of test-negative design case-control studies. The Lancet: Infectious Diseases 2014; 14(12):1228-39. (IF: 19.45, the top journal in category ‘Infectious diseases’ )

Gefenaite G, Bijlsma MJ, Bos HJ, Hak E. Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children? Analysis of 2002 to 2013 data. Eurosurveillance. 2014; 19(44). (IF: 5.86)

Bijlsma MJ. Commentary: G-computation might be used to control for confounding when estimating the population-level impact of interventions through outcome distribution curves. Journal of Clinical Epidemiology. 2014. 67(11):1286. (IF: 3.42)

Bijlsma MJ, Hak E, Bos HJ, De Jong-van den Berg LTW, Janssen F. Assessing the effect of a guideline change on prevalence of benzodiazepine use by including the birth cohort dimension: interrupted time series studies. Pharmacoepidemiology & Drug Safety 2013; 22(9): 933-941. (IF: 3.17)

Klaassens M, Bijlsma MJ. New places of remembrance: Individual Web memorials in the Netherlands. Death Studies 2013. DOI: 10.1080/07481187.2012.742474. (IF: 0.674)

Bijlsma MJ, Hak E, Bos HJ, De Jong-Van den Berg LTW, Janssen F. Inclusion of the birth cohort dimension improved description and explanation of trends in statin use. Journal of Clinical Epidemiology 2012; 65: 1052-1060. (IF: 3.42)

 

Under review & working papers

See my Curriculum Vitae PDF file. Most of my under review & working papers are not listed online so that a search of the title does not easily identify the authors. This is done to keep the review process adequately blinded. Exceptions are MPIDR working papers.

Bijlsma MJ, Wilson B. A new approach to understanding the socio-economic determinants of fertility over the life course. MPIDR Working Paper WP-2017-013. (2017).

Riffe T, Van Raalte A, Bijlsma MJ. Healthy life expectancy, mortality, and age prevalence of morbidity. MPIDR Working Paper WP-2017-015. (2017).

 

Dutch language publications

Van Doorn E, Darvishian M, Dijkstra F, Bijlsma MJ, Donker GA, de Lange MMA, Cadenau LM, Hak E, Meijer A. Effectiviteit van influenzavaccinatie in Nederland: dominant circulerend virustype en match zijn bepalend. Nederlands Tijdschrift voor Geneeskunde 2017;161:D1648.

Bijlsma MJ, Janssen F, Bos HJ, Kamphuisen PW, Vansteelandt S, Hak E. Associatie tussen gebruik van statine en cardiovasculaire sterfte in Nederland 1994-2010: een ecologische studie. Medisch Farmaceutische Mededelingen 2015; 4: 23-5.

Bijlsma MJ, Oortgiesen BE, Beernink RHJ, Bos J, Wilffert B, Hak E. Het effect van de CBG-waarschuwing op de trend in SSRI-gebruik in Nederland van 1998 tot 2010. Pharmaceutisch Weekblad Wetenschappelijk Platform 2014;8:A1406.

Bijlsma MJ, Bos HJ, De Jong-van den Berg LTW, Janssen F. Periodepatronen, leeftijdpatronen en cohortpatronen in de prevalentie van benzodiazepinegebruik en statinegebruik: de invloed van veranderde richtlijnen. Pharmaceutisch Weekblad Wetenschappelijk Platform 2011; 5(10): 169-173.

Bijlsma MJ, Moerman JM. Herdenken in een post-geografische ruimte. Rooilijn 2010; 43(1) pp. 22-7.

Advertisements